CompletedNot Applicable

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

United States41 participantsStarted 2022-09-19

Plain-language summary

The study is designed as a multicenter prospective registry study evaluating the efficacy of the self-assembling peptide in the prevention of stricture formation after endoscopic resection as part of standard medical care. No experimental interventions will be performed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older * Patients at high-risk for esophageal stricture formation defined as undergoing endoscopic resection in the esophagus involving more than 50% of the circumference Exclusion Criteria: * Any standard contraindication to anesthesia and/or endoscopy * Participation in another research protocol that could interfere or influence the outcomes measures of the present study.

What they're measuring

Rate of stricture formation

Timeframe: 12 months

Trial details

NCT IDNCT05581173

SponsorAdventHealth

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-23

View on ClinicalTrials.gov More Esophageal Stricture trials